0001775697-21-000379.txt : 20210426 0001775697-21-000379.hdr.sgml : 20210426 20210426122115 ACCESSION NUMBER: 0001775697-21-000379 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210426 PERIOD START: 20211130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon Strategic Funds, Inc. CENTRAL INDEX KEY: 0000737520 IRS NUMBER: 133272460 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-03940 FILM NUMBER: 21852834 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Strategic Funds, Inc. DATE OF NAME CHANGE: 20060518 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS PREMIER NEW LEADERS FUND INC DATE OF NAME CHANGE: 20021213 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS NEW LEADERS FUND INC DATE OF NAME CHANGE: 19920703 0000737520 S000015656 BNY Mellon Global Stock Fund C000042690 Class A DGLAX C000042691 Class C DGLCX C000042692 Class I DGLRX C000130440 Class Y DGLYX NPORT-P 1 primary_doc.xml NPORT-P false 0000737520 XXXXXXXX S000015656 C000042690 C000042691 C000042692 C000130440 BNY Mellon Strategic Funds, Inc. 811-03940 0000737520 549300KOXIZHC0IVRM71 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon Global Stock Fund S000015656 549300ZJ8KEGRL2S8K51 2021-11-30 2021-02-28 N 1415402034.86 4037607.11 1411364427.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 N AMPHENOL CORP 549300D3L3G0R4U4VT04 AMPHENOL CORP 032095101 277500.00 NS USD 34876200.00 2.4710981313026 Long EC CORP US N 1 N N N ADOBE INC FU4LY2G4933NH2E1CP29 ADOBE INC 00724F101 61300.00 NS USD 28177771.00 1.9964915117579 Long EC CORP US N 1 N N N COLGATE-PALMOLIVE CO 335800YWKI47DGFKWB26 COLGATE-PALMOLIVE CO 194162103 358100.00 NS USD 26929120.00 1.9080203149891 Long EC CORP US N 1 N N N JOHNSON & JOHNSON 549300G0CFPGEF6X2043 JOHNSON & JOHNSON 478160104 186200.00 NS USD 29505252.00 2.0905480838168 Long EC CORP US N 1 N N N CISCO SYSTEMS INC 8E6NF1YAL0WT6CWXXV93 CISCO SYSTEMS INC 17275R102 576000.00 NS USD 25845120.00 1.8312152050765 Long EC CORP US N 1 N N N ORACLE CORP 529900MIMKY9RU60Z323 ORACLE CORP 68389X105 451700.00 NS USD 29139167.00 2.064609708667 Long EC CORP US N 1 N N N AUTOMATIC DATA PROCESSING INC HGBOLILQXWER4SAL2I23 AUTOMATIC DATA PROCESSING INC 053015103 156300.00 NS USD 27199326.00 1.9271653348498 Long EC CORP US N 1 N N N STRYKER CORP 5493002F0SC4JTBU5137 STRYKER CORP 863667101 128200.00 NS USD 31112858.00 2.2044524708335 Long EC CORP US N 1 N N N EDWARDS LIFESCIENCES CORP YA13X31F3V31L8TMPR58 EDWARDS LIFESCIENCES CORP 28176E108 361500.00 NS USD 30040650.00 2.1284828644782 Long EC CORP US N 1 N N N WALT DISNEY CO/THE 549300GZKULIZ0WOW665 WALT DISNEY CO/THE 254687106 190400.00 NS USD 35993216.00 2.55024253781 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 198600.00 NS USD 46150668.00 3.2699327751637 Long EC CORP US N 1 N N N ILLUMINA INC SQ95QG8SR5Q56LSNF682 ILLUMINA INC 452327109 50500.00 NS USD 22190205.00 1.5722519686411 Long EC CORP US N 1 N N N INTUITIVE SURGICAL INC 54930052SRG011710797 INTUITIVE SURGICAL INC 46120E602 41500.00 NS USD 30577200.00 2.1664992682822 Long EC CORP US N 1 N N N COGNIZANT TECHNOLOGY SOLUTIONS CORP 5493006IEVQEFQO40L83 COGNIZANT TECHNOLOGY SOLUTIONS CORP 192446102 396100.00 NS USD 29105428.00 2.0622191850477 Long EC CORP US N 1 N N N FORTINET INC 549300O0QJWDBAS0QX03 FORTINET INC 34959E109 52084.00 NS USD 8794383.40 0.6231121620388 Long EC CORP US N 1 N N N NIKE INC 787RXPR0UX0O0XUXPZ81 NIKE INC 654106103 231000.00 NS USD 31134180.00 2.2059632075065 Long EC CORP US N 1 N N N MASTERCARD INC AR5L2ODV9HN37376R084 MASTERCARD INC 57636Q104 124000.00 NS USD 43877400.00 3.1088639572664 Long EC CORP US N 1 N N N WATERS CORP 5T547R1474YC9HOD8Q74 WATERS CORP 941848103 106900.00 NS USD 29277772.00 2.0744303472827 Long EC CORP US N 1 N N N TJX COS INC/THE V167QI9I69W364E2DY52 TJX COS INC/THE 872540109 440000.00 NS USD 29035600.00 2.0572716322664 Long EC CORP US N 1 N N N TEXAS INSTRUMENTS INC WDJNR2L6D8RWOEB8T652 TEXAS INSTRUMENTS INC 882508104 176100.00 NS USD 30336747.00 2.149462350299 Long EC CORP US N 1 N N N TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 549300KB6NK5SBD14S87 TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 874039100 475600.00 NS USD 59897064.00 4.2439119778219 Long EC CORP TW N 1 N N N IPG PHOTONICS CORP 5493002KZ51CADQ94G15 IPG PHOTONICS CORP 44980X109 78700.00 NS USD 17892445.00 1.2677409638646 Long EC CORP US N 1 N N N FASTENAL CO 529900PP0C7H2HHPSJ32 FASTENAL CO 311900104 544600.00 NS USD 25253102.00 1.7892687036372 Long EC CORP US N 1 N N N FANUC CORP 529900QTSW745LOKW705 FANUC CORP N/A 119200.00 NS 29454739.90 2.0869691286577 Long EC CORP JP N 1 N N N ROCHE HOLDING AG 549300U41AUUVOAAOB37 ROCHE HOLDING AG N/A 80300.00 NS 26301747.93 1.8635688566935 Long EC CORP CH N 1 N N N LVMH MOET HENNESSY LOUIS VUITTON SE IOG4E947OATN0KJYSD45 LVMH MOET HENNESSY LOUIS VUITTON SE N/A 46000.00 NS 29138182.50 2.0645399534726 Long EC CORP FR N 1 N N N SMC CORP 353800O40V08DOZ70X62 SMC CORP N/A 41500.00 NS 24488484.45 1.7350929333708 Long EC CORP JP N 1 N N N JARDINE MATHESON HOLDINGS LTD 529900N9ELYOWQV4FW14 JARDINE MATHESON HOLDINGS LTD N/A 264500.00 NS USD 13838640.00 0.9805150057566 Long EC CORP BM N 1 N N N NESTLE SA 3358008SYYY9CPWH5D94 NESTLE SA N/A 215100.00 NS 22464134.56 1.5916608154714 Long EC CORP CH N 1 N N N EXPERIAN PLC 635400RXXHHYT1JTSZ26 EXPERIAN PLC N/A 714500.00 NS 22626383.02 1.6031566741462 Long EC CORP JE N 1 N N N CERNER CORP 549300L4UJ40IEVVI304 CERNER CORP 156782104 187935.00 NS USD 12993825.90 0.9206570354557 Long EC CORP US N 1 N N N SHIN-ETSU CHEMICAL CO LTD 353800PX8Q64N86H5W41 SHIN-ETSU CHEMICAL CO LTD N/A 177700.00 NS 28923448.57 2.0493253196206 Long EC CORP JP N 1 N N N SGS SA 2138007JNS19JHNA2336 SGS SA N/A 7900.00 NS 22536689.94 1.59680161246 Long EC CORP CH N 1 N N N COMPASS GROUP PLC 2138008M6MH9OZ6U2T68 COMPASS GROUP PLC N/A 1018000.00 NS 20635939.08 1.462126908845 Long EC CORP GB N 1 N N N NOVO NORDISK A/S 549300DAQ1CVT6CXN342 NOVO NORDISK A/S N/A 436800.00 NS 31038512.46 2.1991848348822 Long EC CORP DK N 1 N N N RECKITT BENCKISER GROUP PLC 5493003JFSMOJG48V108 RECKITT BENCKISER GROUP PLC N/A 267400.00 NS 22352500.80 1.5837511815169 Long EC CORP GB N 1 N N N CSL LTD 529900ECSECK5ZDQTE14 CSL LTD N/A 115300.00 NS 23296350.65 1.650626173648 Long EC CORP AU N 1 N N N AIA GROUP LTD ZP5ILWVSYE4LJGMMVD57 AIA GROUP LTD N/A 3621800.00 NS 45316567.50 3.2108339000894 Long EC CORP HK N 1 N N N L'OREAL SA 529900JI1GG6F7RKVI53 L'OREAL SA N/A 76600.00 NS 27985299.84 1.9828542713531 Long EC CORP FR N 1 N N N CLP HOLDINGS LTD 25490002BUTSMP94GO68 CLP HOLDINGS LTD N/A 1301000.00 NS 12688878.29 0.8990504536258 Long EC CORP HK N 1 N N N KEYENCE CORP 529900M7PQBS7A89DZ11 KEYENCE CORP N/A 105328.00 NS 49959038.23 3.5397688398342 Long EC CORP JP N 1 N N N CANADIAN NATIONAL RAILWAY CO 3SU7BEP7TH9YEQOZCS77 CANADIAN NATIONAL RAILWAY CO N/A 134200.00 NS 14648532.14 1.0378986356736 Long EC CORP CA N 1 N N N KONE OYJ 2138001CNF45JP5XZK38 KONE OYJ N/A 235400.00 NS 18768165.17 1.3297887349988 Long EC CORP FI N 1 N N N NOVARTIS AG 5493007HIVTX6SY6XD66 NOVARTIS AG N/A 310000.00 NS 26646402.46 1.8879888096995 Long EC CORP CH N 1 N N N BOOKING HOLDINGS INC FXM8FAOHMYDIPD38UZ17 BOOKING HOLDINGS INC 09857L108 13110.00 NS USD 30526766.10 2.1629258538608 Long EC CORP US N 1 N N N ALPHABET INC 5493006MHB84DD0ZWV18 ALPHABET INC 02079K107 18397.00 NS USD 37472113.42 2.6550274814378 Long EC CORP US N 1 N N N INDUSTRIA DE DISENO TEXTIL SA 549300TTCXZOGZM2EY83 INDUSTRIA DE DISENO TEXTIL SA N/A 865000.00 NS 28502511.63 2.019500496795 Long EC CORP ES N 1 N N N LINDE PLC 8945002PAZHZLBGKGF02 LINDE PLC N/A 126500.00 NS USD 30900155.00 2.1893817353226 Long EC CORP IE N 1 N N N ALIMENTATION COUCHE-TARD INC 549300OSW32RVX8CCZ87 ALIMENTATION COUCHE-TARD INC N/A 874700.00 NS 26290487.98 1.8627710506996 Long EC CORP CA N 1 N N N DREYFUS INSTITUTIONAL PREFERRE 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Plus Money Market Fund N/A 27280701.12 OU Other Units USD 27280701.12 1.9329310406023 Long STIV RF US N 1 2099-12-01 Variable 0.070627 N N N N N N 2021-04-23 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10236bnymello-february20211.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon Global Stock Fund

February 28, 2021 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 98.0%

     

Australia - 1.7%

     

CSL

   

115,300

 

23,296,351

 

Canada - 2.9%

     

Alimentation Couche-Tard, Cl. B

   

874,700

 

26,290,488

 

Canadian National Railway

   

134,200

 

14,648,532

 
    

40,939,020

 

Denmark - 2.2%

     

Novo Nordisk, Cl. B

   

436,800

 

31,038,512

 

Finland - 1.3%

     

Kone, Cl. B

   

235,400

 

18,768,165

 

France - 4.1%

     

L'Oreal

   

76,600

 

27,985,300

 

LVMH

   

46,000

 

29,138,183

 
    

57,123,483

 

Hong Kong - 5.1%

     

AIA Group

   

3,621,800

a

45,316,567

 

CLP Holdings

   

1,301,000

 

12,688,878

 

Jardine Matheson Holdings

   

264,500

a

13,838,640

 
    

71,844,085

 

Ireland - 1.6%

     

Experian

   

714,500

 

22,626,383

 

Japan - 9.4%

     

FANUC

   

119,200

 

29,454,740

 

Keyence

   

105,328

 

49,959,038

 

Shin-Etsu Chemical

   

177,700

 

28,923,449

 

SMC

   

41,500

 

24,488,484

 
    

132,825,711

 

Spain - 2.0%

     

Industria de Diseno Textil

   

865,000

a

28,502,512

 

Switzerland - 6.9%

     

Nestle

   

215,100

 

22,464,135

 

Novartis

   

310,000

 

26,646,402

 

Roche Holding

   

80,300

a

26,301,748

 

SGS

   

7,900

 

22,536,690

 
    

97,948,975

 

Taiwan - 4.3%

     

Taiwan Semiconductor Manufacturing, ADR

   

475,600

 

59,897,064

 

United Kingdom - 5.2%

     

Compass Group

   

1,018,000

a

20,635,939

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 98.0% (continued)

     

United Kingdom - 5.2% (continued)

     

Linde

   

126,500

 

30,900,155

 

Reckitt Benckiser Group

   

267,400

 

22,352,501

 
    

73,888,595

 

United States - 51.3%

     

Adobe

   

61,300

a

28,177,771

 

Alphabet, Cl. C

   

18,397

a

37,472,113

 

Amphenol, Cl. A

   

277,500

 

34,876,200

 

Automatic Data Processing

   

156,300

 

27,199,326

 

Booking Holdings

   

13,110

a

30,526,766

 

Cerner

   

177,648

 

12,282,583

 

Cisco Systems

   

576,000

 

25,845,120

 

Cognizant Technology Solutions, Cl. A

   

396,100

 

29,105,428

 

Colgate-Palmolive

   

358,100

 

26,929,120

 

Edwards Lifesciences

   

361,500

a

30,040,650

 

Fastenal

   

544,600

 

25,253,102

 

Fortinet

   

58,196

a

9,826,395

 

Illumina

   

50,500

a

22,190,205

 

Intuitive Surgical

   

41,500

a

30,577,200

 

IPG Photonics

   

78,700

a

17,892,445

 

Johnson & Johnson

   

186,200

 

29,505,252

 

Mastercard, Cl. A

   

124,000

 

43,877,400

 

Microsoft

   

198,600

 

46,150,668

 

NIKE, Cl. B

   

231,000

 

31,134,180

 

Oracle

   

451,700

 

29,139,167

 

Stryker

   

128,200

 

31,112,858

 

Texas Instruments

   

176,100

 

30,336,747

 

The TJX Companies

   

440,000

 

29,035,600

 

The Walt Disney Company

   

190,400

a

35,993,216

 

Waters

   

106,900

a

29,277,772

 
    

723,757,284

 

Total Common Stocks (cost $565,597,032)

   

1,382,456,140

 
  

1-Day
Yield (%)

     

Investment Companies - 1.9%

     

Registered Investment Companies - 1.9%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares
(cost $27,280,701)

 

0.07

 

27,280,701

b

27,280,701

 

Total Investments (cost $592,877,733)

 

99.9%

 

1,409,736,841

 

Cash and Receivables (Net)

 

.1%

 

1,627,587

 

Net Assets

 

100.0%

 

1,411,364,428

 

ADR—American Depository Receipt

a Non-income producing security.


b Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
BNY Mellon Global Stock Fund

February 28, 2021 (Unaudited)

The following is a summary of the inputs used as of February 28, 2021 in valuing the fund’s investments:

      
 

Level 1 - Unadjusted Quoted Prices

Level 2 - Other Significant Observable Inputs

 

Level 3 -Significant Unobservable Inputs

Total

Assets ($)

 

 

 

 

 

Investments in Securities:

 

 

 

 

 

Equity Securities - Common Stocks

1,382,456,140

  

-

1,382,456,140

Investment Companies

27,280,701

-

 

-

27,280,701

      

See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a


result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At February 28, 2021, accumulated net unrealized appreciation on investments was $816,859,108, consisting of $817,509,804 gross unrealized appreciation and $650,696 gross unrealized depreciation.

At February 28, 2021, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.